Sopheon « Terug naar discussie overzicht

Sopheon september 2023

14 Posts
Spectator
0
Wie begrijpt wat er aan de hand is? Het lijkt dat het Sopheon voor de wind gaat. Toch loopt de waarde van het aandeel sinds 2018 alleen maar achteruit.
Tritace
0
Sopheon customers win three straight Outstanding Corporate Innovator Awards
Forward-thinking companies have embraced the market trend of InnovationOps to operationalize their innovation efforts, reducing risk and increasing positive outcomes

PITTSBURGH — September 6, 2023 — Sopheon, the InnovationOps software company, announced that its customers have won the Outstanding Corporate Innovator (OCI) Award for three consecutive years. These elite global corporations are recognized by the Product Development & Management Association (PDMA) for their innovation success.

pdma-oci-logo-minIn its 36th year, the OCI Award is the only global innovation award that recognizes sustained and quantifiable business results from new products and services. The PDMA is a global community of professionals whose skills, expertise and experience power the most recognized and respected innovative companies in the world. The founding principle is that successful commercialization of products and innovation requires efficient cross-organizational processes from concept through end-of-life exit.

“Sopheon is proud to work alongside many of the most innovative companies in the world,” said Greg Coticchia, CEO of Sopheon. “People often associate the word ‘innovation’ with young, start-up companies. But innovation is everywhere. A glance at the most successful long-term enterprises reveals innovation at every turn. Great companies are constantly redefining, reimagining and reinventing. The most recent winners of the Corporate Innovator Award are outstanding examples of companies that combine great vision and strategy with a world-class innovation management system.”

Sopheon’s software offerings support InnovationOps thinking and principles that help organizations with managing discovery, product management, project management, portfolio management and governance. Sopheon enables a perfect combination of creativity and structure that allows companies to respond to market needs in real time.

To experience the power of Sopheon’s InnovationOps software, visit Accolade®, Acclaim™ Ideas, Acclaim™ Projects and Acclaim™ Products.

About Sopheon
Sopheon (LON:SPE) empowers organizations to change the world while achieving exceptional long-term revenue growth and profitability. By operationalizing the entire innovation life cycle, Accolade® and Acclaim™ software and expertise enable innovation, product and project professionals to accomplish the full range of InnovationOps tasks to drive innovation at scale. Sopheon’s solutions have been implemented in over 50 countries by hundreds of blue-chip customers, including the three most recent winners of the PDMA’s Outstanding Corporate Innovator Award. Sopheon is listed on the AIM Market of the London Stock Exchange.

Accolade® and Acclaim™ are trademarks of Sopheon plc.

www.sopheon.com/about/press-releases/...
Tritace
0
Sopheon sets new standard for InnovationOps
Steady march of quarterly enhancements positions Accolade as leading choice for innovation and product professionals

PITTSBURGH, Sept. 12, 2023 - Sopheon, the InnovationOps software company, announced the launch of Accolade 16.0, featuring improved collaboration capabilities, enhanced scenario planning and easier financial management through an expanded integration with Acclaim Projects. Accolade strengthens innovation and governance processes, and helps companies improve time-to-value.

The release of Accolade 16.0 reflects Sopheon’s recognition of the growing industry adoption of InnovationOps, a holistic framework for operationalizing innovation from incremental to breakthrough across all areas of the company. Companies that embrace InnovationOps can effectively scale innovation for consistent and profitable growth. Accolade 16.0 highlights include:

Expanded Acclaim Projects integration, which results in improved cost management. Managers can track the percentage of expenses that can be capitalized for better financial management. Additionally, project, schedule and financial health scores provide deeper insights into the status of innovation projects.
Enhancements to scenario planning and prioritization that make it easier than ever to find and add any project to the Portfolio Planner. An improved workflow leads to greater efficiencies throughout the innovation process.
Improved collaboration simplifies the process of connecting communication channels and enhances collaborative editing.
New user interface simplifies resource and scenario planning. Accolade 16.0 enhances the look and feel of the interface for improvements when viewing available project resources.
“In this version of Accolade, Sopheon has completely reimagined resource and capacity planning,” said Mike Bauer, chief product officer of Sopheon. “In addition to resulting in better product and portfolio decisions, these improvements help keep innovation programs heading in the proper strategic direction. Over the past year, Sopheon has made enormous strides in Accolade’s capabilities. Our commitment to regular quarterly updates is designed to ensure that Accolade continues to set the industry standard for enterprise innovation management.”

Accolade is the industry’s most complete InnovationOps tool for managing strategy, governance and portfolios. It connects entire organizations and empowers product and innovation teams to be strategic and agile when responding to marketplace change and when delivering new products. The full transparency provided by Accolade makes it possible for companies to oversee governance, portfolio and strategy at an executive and leadership level, as well as manage products and projects at a team member level.

To experience the power of Sopheon’s InnovationOps software, visit Accolade®, Acclaim™ Ideas, Acclaim™ Projects and Acclaim™ Products

www.sopheon.com/about/press-releases/...
Tritace
0
quote:

Spectator schreef op 10 september 2023 12:56:

Wie begrijpt wat er aan de hand is? Het lijkt dat het Sopheon voor de wind gaat. Toch loopt de waarde van het aandeel sinds 2018 alleen maar achteruit.
Mogelijk dat beleggers eerst klinkende cijfers in omzet en winst willen zien.
Nauwelijks handel in het aandeel helpt natuurlijk ook niet.
Ik verwacht dat de omzet vanaf 2024 e.v. substantieel gaat stijgen
[verwijderd]
0
nog ff doorbijten, verwacht eind dit jaar, ruim 10 pond. komen ook nog 2 grote orders van 2 militaire bestaande klanten. volgens het verslag van 24 augustus 2023.
volgend jaar kon het welis heel intresant gaan worden met soof. ligt er ook aan wat er allemaal in de wereld gaat gebeuren. time will tell.
Spectator
0
Spectator
0
Beste Tritace en hunky,
ik hoop ontzettend dat jullie gelijk krijgen.
Een heel andere mening, helaas, vond ik hier: nl.investing.com/equities/sopheon
Arie de Beuker
0
Volgens technische analyse zeggen ze verkopen maar de gezien de huidige ontwikkelingen, dus fundamenteel zou Sopheon best eens een mooie koopkans kunnen zijn.

Gr
Arie de Beuker
[verwijderd]
1
investing zegt verkopen , terwijl finn cap een target price van 12,50 pond blijft volhouden. je moet je eigen gevoel volgen, ik zit vol in soof. heb er genoeg koop niks meer bij, maar dit is wel een leuk koop prijsje. vorige maand heeft veradace partners nog voor rond de 2 miljoen euro aandelen gekocht. zouden ze dat in de blind hebben gedaan? ik denk zelf van niet. valt wel op dat de laatste tijd met een klein aantal de koers naar beneden wordt gedrukt. dat gebeurde ook in ik dacht in 2018, binnen een jaar stond de koers ruim op 14 pond.
wat er ook gebeurt, ik hou ze stug vast. goed weekend all.
Spectator
0
Ook ik zit flink in Soof, Hunkey. Hopelijk kunnen we Soofs goede resultaten een keer terugzien in de koers.
Die kleine koersdrukkende dagelijkse aankopen blijf ik vreemd vinden.
14 Posts
Aantal posts per pagina:  20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Markt vandaag

AEX 882,63 +12,36 +1,42% 26 apr
AMX 914,42 -2,12 -0,23% 26 apr
ASCX 1.198,74 +7,95 +0,67% 26 apr
BEL 20 3.874,87 +16,93 +0,44% 26 apr
Germany40^ 18.177,90 +260,62 +1,45% 26 apr
US30^ 38.211,61 0,00 0,00% 26 apr
US500^ 5.095,29 0,00 0,00% 26 apr
Nasd100^ 17.698,09 0,00 0,00% 26 apr
Japan225^ 38.345,55 0,00 0,00% 26 apr
WTI 83,64 0,00 0,00% 26 apr
Brent 87,99 0,00 0,00% 26 apr
EUR/USD 1,0693 -0,0036 -0,34% 27 apr
BTC/USD 63.490,70 -489,17 -0,76% 02:21
Gold spot 2.337,95 0,00 0,00% 26 apr
#/^ Index indications calculated real time, zie disclaimer
HOGE RENDEMENTEN OP DE IEX-MODELPORTEFEUILLES > WORD NU ABONNEE EN PROFITEER VAN MAAR LIEFST 67% KORTING!

Stijgers & Dalers

Stijgers Laatst +/- % tijd
ASMI 623,800 +42,200 +7,26% 26 apr
ASML 858,800 +25,100 +3,01% 26 apr
PROSUS 31,625 +0,815 +2,65% 26 apr
Dalers Laatst +/- % tijd
IMCD 141,700 -7,300 -4,90% 26 apr
ABN AMRO BANK N.V. 15,210 -0,665 -4,19% 26 apr
BESI 130,400 -5,600 -4,12% 26 apr

EU stocks, real time, by Cboe Europe Ltd.; Other, Euronext & US stocks by NYSE & Cboe BZX Exchange, 15 min. delayed
#/^ Index indications calculated real time, zie disclaimer, streaming powered by: Infront